Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus-associated lymphomas.

Maher K Gandhi1

  • 1Tumor Immunology Lab, Level I, CRC, QIMR, Brisbane, 4006, Queensland, Australia. maher.gandhi@qimr.edu.au

Expert Review of Anti-Infective Therapy
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Leukemia·2026
Same author

SIGN of the times: DC-SIGN and the follicular lymphoma niche.

Blood·2026
Same author

Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Blood·2026
Same author

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Large B cell lymphoma microenvironment archetype profiles.

Cancer cell·2025
Same author

The Epstein-Barr Virus in Classical Hodgkin Lymphoma: Pathogenesis, Immunobiology, and Therapeutic Implications.

Current topics in microbiology and immunology·2025

Epstein-Barr virus, initially thought to be rare, is now known to infect 95% of people globally. This virus is linked to various cancers, including lymphomas, and persists for life.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Epstein-Barr virus (EBV) discovery via electron microscopy of Burkitt's lymphoma.
  • Initial hypothesis: EBV linked to a specific African childhood lymphoma.
  • Over 40 years of research revealed a more complex picture.

Purpose of the Study:

  • To review the biology and epidemiology of Epstein-Barr virus.
  • To explore the association of EBV with various malignancies.
  • To update understanding beyond initial simplistic views.

Main Methods:

  • Review of scientific literature on Epstein-Barr virus.
  • Analysis of epidemiological data on EBV seroprevalence.
  • Examination of experimental models (primate infection, SCID mice).

Related Experiment Videos

Main Results:

  • Epstein-Barr virus has a worldwide seroprevalence of approximately 95%.
  • EBV persists for life in host B lymphocytes.
  • EBV infection causes lymphoma in New World primates and B-cell disorders in mice.

Conclusions:

  • Early assumptions about Epstein-Barr virus were overly simplistic.
  • Epstein-Barr virus is implicated in a wide range of lymphoid and other cancers.
  • Ongoing research continues to define EBV's role in human diseases.